BMC Medical Ethics 15 (1):83 (2014)

Abstract
Submission of study protocols to research ethics committees constitutes one of the earliest stages at which planned trials are documented in detail. Previous studies have investigated the amendments requested from researchers by RECs, but the type of issues raised during REC review have not been compared by sponsor type. The objective of this study was to identify recurring shortcomings in protocols of drug trials based on REC comments and to assess whether these were more common among industry-sponsored or non-industry trials
Keywords Research ethics committees  Ethical review  Research protocols  Drug trials  Sponsorship  Pharmaceutical industry  Shortcomings
Categories (categorize this paper)
DOI 10.1186/1472-6939-15-83
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 61,025
Through your library

References found in this work BETA

View all 7 references / Add more references

Citations of this work BETA

Add more citations

Similar books and articles

Clinical Trials: Two Neglected Ethical Issues.A. Herxheimer - 1993 - Journal of Medical Ethics 19 (4):211-218.
Institutional Mistrust in the Organization of Pharmaceutical Clinical Trials.Jill A. Fisher - 2008 - Medicine, Health Care and Philosophy 11 (4):403-413.
The Protection of Patients' Rights in Clinical Trials.Marek Czarkowski - 2006 - Science and Engineering Ethics 12 (1):131-138.

Analytics

Added to PP index
2014-12-14

Total views
24 ( #445,994 of 2,439,595 )

Recent downloads (6 months)
1 ( #433,110 of 2,439,595 )

How can I increase my downloads?

Downloads

My notes